(6S)-rotigotine
Also known as Leganto®, N-0437, Neupro®, Rotigotine, (6S)-6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol
Rotigotine, sold under the brand name Neupro among others, is a dopamine agonist of the non-ergoline class of medications indicated for the treatment of Parkinson's disease and restless legs syndrome. It is formulated as a once-daily transdermal patch which provides a slow and constant supply of the drug over the course of 24 hours.
Key facts
- Drug.Verifiedfields
- changed
- Drug.verifiedrevid
- 464383949
- Drug.image
- Rotigotine.svg
- Drug.image_class
- skin-invert-image
- Drug.image2
- Rotigotine 3D-Structure Xtal.png
- Drug.image_class2
- bg-transparent
- Drug.width2
- 271
- Drug.tradename
- Neupro, Leganto
- Drug.MedlinePlus
- a607059
- Drug.DailyMedID
- Rotigotine
- Drug.pregnancy_AU
- B3
- Drug.routes_of_administration
- Transdermal
- Drug.ATC_prefix
~4 min read
Article
5 sectionsContents
- Side effects
- Pharmacology
- History
- References
- External links
Rotigotine, sold under the brand name Neupro among others, is a dopamine agonist of the non-ergoline class of medications indicated for the treatment of Parkinson's disease and restless legs syndrome. It is formulated as a once-daily transdermal patch which provides a slow and constant supply of the drug over the course of 24 hours.
Like other dopamine agonists, rotigotine has been shown to possess antidepressant effects and may be useful in the treatment of depression as well.